Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation

BACKGROUND: Left ventricular assist device (LVAD) thrombosis is clinically devastating and impacts the cost effectiveness of LVAD therapy for advanced heart failure. Anticoagulation and antiplatelet therapies represent the standard of care to mitigate LVAD thrombosis. Phosphodiesterase type 5 inhibi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Xanthopoulos, Andrew, Tryposkiadis, Konstantinos, Triposkiadis, Filippos, Fukamachi, Kiyotaka, Soltesz, Edward G., Young, James B., Wolski, Kathy, Blackstone, Eugene H., Starling, Randall C.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660717/
https://ncbi.nlm.nih.gov/pubmed/32648508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015897
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados